Skip to content

InsiderTradesSIGMA

RecommendationsTOP Fundamental picks TerminalNEW

Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FR US DE CH GB CA IT ES NL BE NO FI DK AU AT IE KR IN JP HK+ 8 markets

Recommendations
Fundamental picks
Terminal
Companies
Insiders
Performance
Backtest
Compare

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Archive

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

Built bySimon Azoulay

All systems operational

IN IN2,453 companies

IN-Listed Companies

Regulator: SEBI (PIT + SAST).

Medi Assist Healthcare

Medicamen Biotech Limited

Santé & Pharma · 3.9bn

Medico Remedies Limited

Santé & Pharma · 4bn

Medplus Health Services Limited

Santé & Pharma · 106bn

Mega Flex Plastics Limited

Chimie & Matériaux · 508m

Megastar Foods Limited

Agroalimentaire · 3.2bn

Megatherm Induction Limited

Industrie · 5.1bn

Meghmani Organics Limited

Chimie & Matériaux · 16bn

Melstar Information Technologies Limited

Technologie · 72m

Menon Bearings Limited

← PreviousPage 28 of 50Next →

Distribution & Commerce · 8.3bn

Mercator Limited

Santé & Pharma · 532m

Metro Brands Limited

Distribution & Commerce · 284bn

Metropolis Healthcare Limited

Santé & Pharma · 81bn

Midwest Limited

Milgrey Finance

Milton Industries Limited

Industrie · 662m

MindTree Limited

Minda Corporation Limited

Industrie · 127bn

Mindteck (India) Limited

Technologie · 7.1bn

Mirza International Limited

Distribution & Commerce · 3.7bn

Mittal Life Style Limited

Luxe & Mode · 435m

Mizzen Ventures

Modern Threads (India) Limited

Distribution & Commerce · 1.6bn

Modison Limited

Industrie · 4bn

Modulex Construction

Mohini Health & Hygiene Limited

Santé & Pharma · 1.1bn

Mohit Industries Limited

Industrie · 382m

Mohota Industries Limited

Moksh Ornaments Limited

Distribution & Commerce · 915m

Mold-Tek Packaging Limited

Distribution & Commerce · 14bn

Mold-Tek Technologies Limited

Technologie · 4.2bn

Monarch Networth Capital Limited

Finance & Banque · 27bn

Moneyboxx Finance Limited

Finance & Banque · 4.9bn

Monolithisch India Limited

Chimie & Matériaux

Monte Carlo Fashions Limited

Luxe & Mode · 11bn

Morarjee Textiles Limited

Distribution & Commerce · 270m

Morepen Laboratories Limited

Santé & Pharma · 24bn

Mos Utility Limited

Énergie · 6.5bn

Moschip Technologies Limited

Technologie · 43bn

Motherson Sumi Systems Limited

Technologie · 921bn

Motherson Sumi Wiring India Limited

Distribution & Commerce · 258bn

Motilal Oswal Financial Services Limited

Finance & Banque · 369bn

Motor & General Fin

Moxsh Overseas Educon Limited

MphasiS Limited

Technologie · 474bn